ORMP icon

Oramed Pharmaceuticals

50 hedge funds and large institutions have $8.15M invested in Oramed Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

29% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 14

43% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 23

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$499K
Puts
$49K
Net Calls
Net Calls Change

Top Buyers

1 +$589K
2 +$262K
3 +$132K
4
Squarepoint
Squarepoint
New York
+$122K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$113K

Top Sellers

1 -$1.81M
2 -$1.6M
3 -$910K
4
Morgan Stanley
Morgan Stanley
New York
-$860K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$431K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.04M
2
$682K
3
$589K
4
$351K
5
$325K
6
$313K
7
$281K
8
$213K
9
$198K
10
$193K
11
$157K
12
$142K
13
$134K
14
$132K
15
$122K
16
$121K
17
$114K
18
$113K
19
$108K
20
$86.5K
21
$74.9K
22
$58.1K
23
$58.1K
24
$47K
25
$46.1K